Cargando…
Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital
BACKGROUND: Our understanding of the severe acute respiratory syndrome coronavirus 2 has evolved since the first reported cases in December 2019, and a greater emphasis has been placed on the hyper-inflammatory response in severely ill patients. The purpose of this study was to determine risk factor...
Autores principales: | Iglesias, Jose I, Vassallo, Andrew V, Sullivan, Jesse B, Elbaga, Yasmine, Patel, Vishal V, Patel, Nikunjkumar, Ayad, Lydia, Benson, Payam, Pittiglio, Marina, Gobran, Emad, Clark, Alexander, Khan, Wajahat, Damalas, Kaliope, Mohan, Rajesh, Singh, Satyendra P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462025/ https://www.ncbi.nlm.nih.gov/pubmed/34616660 http://dx.doi.org/10.5492/wjccm.v10.i5.244 |
Ejemplares similares
-
RISK FACTORS FOR THE DEVELOPMENT OF ACUTE KIDNEY INJURY OCCURRING IN PATIENTS WITH COVID-19 ADMITTED TO THE ICU
por: IGLESIAS, JOSE, et al.
Publicado: (2021) -
A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial
por: Iglesias, Jose, et al.
Publicado: (2020) -
Factors associated with increased mortality in hospitalized COVID-19 patients
por: Shah, Chirag, et al.
Publicado: (2020) -
Acute Kidney Injury Associated with Severe SARS-CoV-2 Infection: Risk Factors for Morbidity and Mortality and a Potential Benefit of Combined Therapy with Tocilizumab and Corticosteroids
por: Iglesias, Jose, et al.
Publicado: (2023) -
What factors are important to new patients when selecting an orthopedic oncologist?
por: Gusho, Charles A, et al.
Publicado: (2022)